Ej. Rushing et al., EXPRESSION OF TELOMERASE RNA COMPONENT CORRELATES WITH THE MIB-1 PROLIFERATION INDEX IN EPENDYMOMAS, Journal of neuropathology and experimental neurology, 56(10), 1997, pp. 1142-1146
Although there is general agreement that certain morphologic subtypes
of ependymoma are benign, the biologic behavior of other ependymal neo
plasms is poorly understood and not clearly related to conventional hi
stopathologic criteria. The absence of universally accepted standards
has prompted the search for more objective biologic markers. Telomeras
e is an RNA-containing enzyme associated with immortality in prolifera
ting stem cells and many tumors. We investigated the proliferative act
ivity of 26 ependymomas as determined by MTB-1 immunolabeling and comp
ared the results with the in situ expression of human telomerase RNA (
hTR) and WHO tumor grade. The study included 9 WHO grade I ependymomas
(6 subependymomas and 3 myxopapillary ependymomas), 13 WHO grade II e
pendymomas, and 4 anaplastic (WHO grade III) ependymomas. The prolifer
ation index (PI) and telomerase RNA expression were significantly incr
eased in grade III ependymomas (p < 0.0001 for PI and p = 0.0015 for h
TR). In these tumors, the PI and hTR expression were highly correlated
(p = 0.0001). Of note, a single case designated grade II showed both
increased proliferative activity and the highest hTR expression detect
ed in this series of ependymal neoplasms. Our results suggest that the
PI and hTR expression may be important biologic markers, independent
of other histopathologic criteria of tumor grade. Future studies exami
ning the correlation of MIB-1 cell kinetics and hTR expression with cl
inical parameters in selected ependymoma subtypes are needed to determ
ine the prognostic relevance of these markers.